Inhibitors to factor VII in congenital factor VII deficiency
Copyright policy )Inhibitors to factor VII in congenital factor VII deficiency
We performed a prospective study of FVII inhibitor occurrence in a large number of patients with FVII deficiency who had received replacement therapy for spontaneous or traumatic bleeding episodes, major or minor surgical interventions or prophylaxis.Inhibitor development was detected in 2.6% (3/115) of patients, but the incidence of de novo inhibitors was 0.8% (1/115). Thus, in this rare bleeding disorder, the development of FVII inhibitors is a very rare complication as rare as that reported in patients with haemophilia B (prevalence of 2–3%)
- Necmettin Erbakan University Turkey
- University of Palermo Italy
- Shiraz University Iran (Islamic Republic of)
- Ege University Turkey
- Guy's and St Thomas' NHS Foundation Trust United Kingdom
Inhibitors, Factor VII Deficiency, rVIIa; FVII deficiency; Inhibitors, Factor VII deficiency, Humans, Factor VII, Inhibitors, Factor VII deficiency, Antibodies
Inhibitors, Factor VII Deficiency, rVIIa; FVII deficiency; Inhibitors, Factor VII deficiency, Humans, Factor VII, Inhibitors, Factor VII deficiency, Antibodies
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).28 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!